Boardroom Alpha
Boardroom Alpha
NCDL · Additional Proxy Materials (DEFA14A) · Filed April 7, 2026

Nuveen Churchill Direct Lending Corp — Additional Proxy Materials (DEFA14A)

Form
DEFA14A
Filed
April 7, 2026
Ticker
NCDL
Accession
0001737924-26-000039
Boardroom Alpha · Filing insights

Nuveen Churchill Direct Lending Corp. requests votes for its 2026 annual meeting; the board urges voting FOR the proposal.

About Nuveen Churchill Direct Lending Corp
Market cap
$655M
1Y TSR
−6.6%
Board grade
B-
Sector
Financial Services
CEO
Kenneth J Kencel
NCDL - DEFA14A - 2026 Definitive Additional Materials (Combined)

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A
Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.           )
Filed by the Registrant
Filed by a Party other than the Registrant
Check the appropriate box:
    Preliminary Proxy Statement
    Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
    Definitive Proxy Statement
    Definitive Additional Materials
    Soliciting Material under § 240.14a-12
NUVEEN CHURCHILL DIRECT LENDING CORP.
(Name of Registrant as Specified In Its Charter)
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)
Payment of Filing Fee (Check the appropriate box):
    No fee required.         
    Fee paid previously with preliminary materials.
    Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11.






 
R08825-LTR Dear Shareholder, We are pleased to invite you to participate at the 2026 Annual Meeting of Shareholders of Nuveen Churchill Direct Lending Corp. (“NCDL”), to be held virtually on May 21, 2026. Your prompt participation is needed to approve NCDL’s proposal outlined in the proxy statement. We kindly request that you review these materials and cast your vote by proxy in advance of the meeting date to ensure that a quorum is reached. Your vote and participation are very important to us, no matter how many or few shares in NCDL you own. We encour- age you to vote your shares using any one of the methods described below. Your prompt response will help us meet shareholder approval requirements before the meeting, thereby reducing the risk of postponement and additional solicitation costs. Thank you for your continued support of NCDL. Sincerely, Robert Paun YOUR VOTE IS VERY IMPORTANT Our Board of Directors recommends that you respond to this solicitation by voting FOR the proposal described in the proxy statement. Nuveen Churchill Direct Lending Corp. FOUR WAYS TO VOTE WWW.PROXYVOTE.COM Please have your proxy card in hand when accessing the website. There are easy-to-follow directions to help you complete the electronic voting instruction form. ONLINE VOTE PROCESSING Mark, sign and date your ballot and return it in the postage-paid envelope provided. MAILPHONE WITH A PROXY CARD Call 1-800-690-6903 with a touch-tone phone to vote using an automated system. WITH A SMARTPHONE Vote by scanning the Quick Response Code or “QR Code” on the Proxy Card/VIF enclosed. QR CODE


 
 
From this filing to the vote

Forecast every director vote the day the proxy files.

Meeting Forecast scores each director up for re-election + every contested situation, rebuilt daily across 6,000+ U.S. public companies. The same model that called the LULU contested proxy lives on every meeting you see here.

Independent — issuer-pays-free, ideology-free, U.S.-owned.

More filings

Other filings from Nuveen Churchill Direct Lending Corp (NCDL)

Reference

Frequently asked questions

When did Nuveen Churchill Direct Lending Corp file this DEFA14A?
Nuveen Churchill Direct Lending Corp (NCDL) filed this Additional Proxy Materials (DEFA14A) with the SEC on April 7, 2026. The accession number assigned by EDGAR is 0001737924-26-000039.
What does a DEFA14A disclose?
DEFA14A is additional definitive proxy soliciting material filed in connection with a shareholder meeting — supplemental letters, slides, or amendments issued after the main proxy statement.
What is the key takeaway from this filing?
Nuveen Churchill Direct Lending Corp. requests votes for its 2026 annual meeting; the board urges voting FOR the proposal. This is Boardroom Alpha's one-line summary of the additional proxy materials; see the full filing text above for the formal disclosure.
Where can I find Nuveen Churchill Direct Lending Corp's prior proxy statements on EDGAR?
The SEC EDGAR browser lists every DEFA14A Nuveen Churchill Direct Lending Corp has filed under CIK 1737924, sortable by date. Use the "View on SEC EDGAR" link in the page header, or browse directly via https://www.sec.gov/cgi-bin/browse-edgar.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer